Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials

Luigia Luciano, Roberto Latagliata, Gabriele Gugliotta, Mario Annunziata, Mario Tiribelli, Bruno Martino, Antonello Sica, Maria Rosaria Esposito, Monica Bocchia, Sara Galimberti, Federica Sora', Francesco Albano, Raffaele Palmieri, Patrizia Pregno, Matteo Dragani, Maria Iovine, Simona Sica, Alessandra Iurlo, Fausto Castagnetti, Gianantonio RostiMassimo Breccia

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Fingerprint

Entra nei temi di ricerca di 'Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials'. Insieme formano una fingerprint unica.

Pharmacology, Toxicology and Pharmaceutical Science